←
Daniel Wacker101 posts
Daniel Wacker avatar

Daniel Wacker

@WackerLab
◷ Joined October 2017▧ 2 Photos and videos
Daniel Wacker avatar
Daniel Wacker@WackerLab·13 Aug 2025

A take on the current state of biased signaling in psychedelic action and psychedelic drug discovery by John McCorvy and I: Biased Signaling in Psychedelic Action | Annual Reviews - go.shr.lc/4lx1pLf

Daniel Wacker avatar
Daniel Wacker@WackerLab·17 Apr 2024

Tetracyclic Antidepressants Activate Understudied Serotonin Receptors: science.org/doi/10.1126/scia… Congrats to @NeuroStruct, @Allyparp, and Audrey Warren for their study in @ScienceAdvances with help from @martafilizola, @NCCATinfo, and @GradSchoolSinai!

Daniel Wacker avatar
Daniel Wacker@WackerLab·8 Oct 2023

Tetracyclic antidepressants potently activate serotonin receptors 5-HT1e and 5-HT1F, explaining some of their clinically observed effects. @NeuroStructure @martafilizola @biorxivpreprint @biorxiv_neursci biorxiv.org/content/10.1101/…

Daniel Wacker avatar
Daniel Wacker@WackerLab·7 Sep 2023

Also, the lab is looking for a Postdoc conducting the type of research described in the paper: CryoEM, membrane protein function and pharmacology, drug discovery.

Daniel Wacker avatar
Daniel Wacker@WackerLab·14 Feb 2022

Thanks to first author @CapperMichael and collaborators including @SchlessingerLab, we report 7 structures, uptake and computational assays. Our mechanistic work complements the beautiful AE1-erythrocyte complex architecture reported by @OliBClarke. biorxiv.org/content/10.1101/…

Daniel Wacker avatar
Daniel Wacker@WackerLab·14 Feb 2022

Sharing our @bioRxivpreprint of “Substrate Binding and Inhibition of the Anion Exchanger 1 Transporter”, in which we reveal how AE1 binds and transports substrates, and how different drugs inhibit the transporter.

Post attachment